Stock listing
Lineage Cell Therapeutics, Inc.
Selected listing: LCTX · TASE · ILA · IL
Lineage Cell Therapeutics, Inc. (TASE:LCTX), Health Technology. Latest release Sep 8, 2026: Lineage Cell Therapeutics Announces Issuance of Patent Underlying…
- Ticker
- TASE:LCTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TASE
- Currency
- ILA
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. (ticker: LCTX) is a public company based in the United States, focused on developing innovative cell therapies. The company aims to improve patient outcomes by leveraging its expertise in regenerative medicine.
Latest news from Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
September 8, 2026
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
July 30, 2026
Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
July 13, 2026
Lineage Cell Therapeutics to Present at B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit
July 6, 2026
Events
Research Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. company profile
View the public company page for Lineage Cell Therapeutics, Inc. on 6ix.
Lineage Cell Therapeutics, Inc. news
Read company news and market updates connected to Lineage Cell Therapeutics, Inc..
Lineage Cell Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Lineage Cell Therapeutics, Inc..
Alternate listings
LCTX:AMEX
US · USD
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
BT3:GETTEX
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
A2PP89:LSX
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
A2PP89:LS
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
LCTX:BOATS
US · USD
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
BT3:FWB
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
BT3:TRADEGATE
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
BT3:DUS
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.
BT3:SWB
DE · EUR
Alternate listing for Lineage Cell Therapeutics, Inc.; the primary context on this page is LCTX:TASE.